COURTNEY A GEARHART

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant BROWNSTOWN, MI NPI 1982911871

General Payments — all program years on this page

$1,116.86

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 58
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $405.61 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $405.6121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $59.054
2022 $198.0112
2023 $454.1921
2024 $405.6121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078055510 Janssen Pharmaceuticals, Inc $24.19 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078055524 Janssen Pharmaceuticals, Inc $19.93 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081704489 Lexicon Pharmaceuticals, Inc. $19.45 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086927649 Novartis Pharmaceuticals Corporation $15.97 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086927663 Novartis Pharmaceuticals Corporation $24.94 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086927675 Novartis Pharmaceuticals Corporation $23.04 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086927697 Novartis Pharmaceuticals Corporation $15.70 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101731609 E.R. Squibb & Sons, L.L.C. $20.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101731631 E.R. Squibb & Sons, L.L.C. $15.49 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101731649 E.R. Squibb & Sons, L.L.C. $16.28 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101731664 E.R. Squibb & Sons, L.L.C. $20.41 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101731690 E.R. Squibb & Sons, L.L.C. $19.43 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104547162 AstraZeneca Pharmaceuticals LP $13.94 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105783190 AstraZeneca Pharmaceuticals LP $14.84 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115652000 Amgen Inc. $17.59 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115652008 Amgen Inc. $17.22 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118262765 Boehringer Ingelheim Pharmaceuticals, Inc. $21.29 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131644838 PFIZER INC. $18.77 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131787779 PFIZER INC. $22.62 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141879529 Merck Sharp & Dohme LLC $23.39 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154855275 Kiniksa Pharmaceuticals International, plc $21.12 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.